Physician profile
Allison A Aggon
NPI 1972759900
$2,216.26
in general payments reported to CMS, 2019-2025
8 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $154 · 2023: $1,342 · 2024: $221 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,350 · Food and Beverage: $562 · Honoraria: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,350.00 |
| Food and Beverage | $561.81 |
| Honoraria | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $2,039.97 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $59.74 | 2023 | Myrisk |
| Davol INC. | $29.19 | 2025 | Phasix Mesh |
| Amgen INC. | $26.07 | 2022 | |
| Glaxosmithkline, LLC. | $20.23 | 2025 | Ojjaara |
| Tersera Therapeutics LLC | $13.93 | 2022 | |
| Tela Bio, INC. | $13.80 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Clozex Medical INC | $13.33 | 2024 | Clozex Skin Closure Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Aggon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.